menu
    • menu

    Company profile for Cytovation

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Immunotherapy is one of the most exciting breakthroughs in modern medicine. Unfortunately, so far only a minority of patients benefit from these advances. Cytovation builds on over 15 years of cutting-edge research from two leading Norwegian institutions; University of Bergen and Haukeland University Hospital. Led by a highly experienced management team and world-renowned experts in tumour biology, an extensive research progra...
    Immunotherapy is one of the most exciting breakthroughs in modern medicine. Unfortunately, so far only a minority of patients benefit from these advances. Cytovation builds on over 15 years of cutting-edge research from two leading Norwegian institutions; University of Bergen and Haukeland University Hospital. Led by a highly experienced management team and world-renowned experts in tumour biology, an extensive research program has focused on engineering synthetic peptides with unique properties. CyPep-1, the company’s lead candidate, is being developed as a first-in-class lytic agent for the treatment of solid tumors.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    CytovationNorway Flag
    Country
    Country
    Norway
    Address
    Address
    Solheimsgaten 11, 5058 Bergen
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.cytovation.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/cytovation-asa/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cytovation Progresses CY-101 for Wnt/?-catenin Cancers
    Cytovation Progresses CY-101 for Wnt/?-catenin Cancers

    23 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/23/3120000/0/en/Cytovation-to-Advance-Development-of-CY-101-for-Cancers-Driven-by-Dysfunction-of-Wnt-%CE%B2-catenin-Signalling-Under-International-Nonproprietary-Name-of-Getacatetide.html

    GLOBENEWSWIRE
    23 Jul 2025
    Share Share
    Cytovation raises 6M for CY-101 Phase 2 in Adrenocortical Carcinoma
    Cytovation raises 6M for CY-101 Phase 2 in Adrenocortical Carcinoma

    23 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/23/3066091/0/en/Cytovation-Raises-US-6m-to-Advance-Phase-2-Development-of-CY-101-in-Adrenocortical-Carcinoma-to-First-Clinical-Readouts.html

    GLOBENEWSWIRE
    23 Apr 2025
    Share Share
    Cytovation Appoints Martin Dewhurst to its Board of Directors
    Cytovation Appoints Martin Dewhurst to its Board of Directors

    13 Feb 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/02/13/3025624/0/en/Cytovation-Appoints-Martin-Dewhurst-to-its-Board-of-Directors.html

    GLOBENEWSWIRE
    13 Feb 2025
    Share Share
    Cancer Research UK, Cytovation Collaborate On Rare Cancer Treatment
    Cancer Research UK, Cytovation Collaborate On Rare Cancer Treatment

    23 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/23/3014007/0/en/Cancer-Research-UK-Cytovation-and-the-Norwegian-Cancer-Society-collaborate-to-advance-treatment-for-rare-cancer.html

    GLOBENEWSWIRE
    23 Jan 2025
    Share Share
    Cytovation To Present CY-101 Trial Data At ESMO 2024
    Cytovation To Present CY-101 Trial Data At ESMO 2024

    13 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/13/2945717/0/en/Cytovation-to-present-full-safety-and-efficacy-data-from-the-CICILIA-Phase-I-IIa-trial-evaluating-CY-101-in-solid-tumors-at-ESMO-2024.html

    GLOBENEWSWIRE
    13 Sep 2024
    Share Share
    Cytovation Announces Appointment of Ellen Lubman to Board of Directors
    Cytovation Announces Appointment of Ellen Lubman to Board of Directors

    20 Dec 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/12/20/2799053/0/en/Cytovation-Announces-Appointment-of-Ellen-Lubman-MBA-to-its-Board-of-Directors.html

    GLOBENEWSWIRE
    20 Dec 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search